3 research outputs found
Study protocol and pilot results of an observational cohort study evaluating effect of red blood cell transfusion on oxygenation and mitochondrial oxygen tension in critically ill patients with anaemia: the INsufficient Oxygenation in the Intensive Care Unit (INOX ICU-2) study
INTRODUCTION: The recently developed protoporphyrin IX-triple state lifetime technique measures mitochondrial oxygenation tension (mitoPO2) in vivo at the bedside. MitoPO2might be an early indicator of oxygen disbalance in cells of critically ill patients and therefore m
Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery
Background: Cardiac surgery is frequently complicated by an acute vascular lung injury and this may be mediated, at least in part, by the (soluble) receptor for advanced glycation end products (sRAGE).Methods: In two university hospital intensive care units, circulating sRAGE was measured together with the 68Gallium-transferrin pulmonary leak index (PLI), a measure of pulmonary vascular permeabiliy, in 60 consecutive cardiac surgery patients stratified by the amount of blood transfusion, within 3 hours of admission to the intensive care.Results: Cardiac surgery resulted in elevated plasma sRAGE levels compared to baseline (315 ± 181 vs 110 ± 55 pg/ml, P = 0.001). In 37 patients the PLI was elevated 50% above normal. The PLI correlated with sRAGE (r2 = 0.11, P = 0.018). Plasma sRAGE discriminated well between those with an elevated PLI and those with a normal PLI (area under the operator curve 0.75; P = 0.035; 95% CI 0.55-0.95), with 91% sensitivity but low specificity of 36% at a cutoff value of 200 pg/mL
The use of cryopreserved platelets in a trauma-induced hemorrhage model
Background: Cryopreserved platelet products can be stored for years and are
mainly used in military settings. Following thawing, cryopreserved platelets
are activated, resulting in faster clot formation but reduced aggregation in
vitro, rendering their efficacy in bleeding unknown. Also, concerns remain on
the safety of these products. The aim was to investigate the efficacy and safety
of cryopreserved platelets in a rat model of traumatic hemorrhage.
Study Design and Methods: After 1 hour of shock, rats (n = 13/group) were
randomized to receive a balanced transfusion pack (1:1:1 red blood cell:plasma:
platelet) made from syngeneic rat blood, containing either liquid stored platelets
or cryopreserved platelets. Primary outcome was the transfusion volume
required to obtain a mean arterial pressure (MAP) of 60 mmHg. Secondary outcomes were coagulation as assessed by thromboelastometry (ROTEM®) and
organ failure as assessed by biochemistry and histopathology.
Results: The transfusion volume to obtain a MAP of 60 mmHg was lower in
animals receiving cryopreserved platelets (5.4 [4.1-7.1] mL/kg) compared to
those receiving liquid stored platelets (7.5 [6.4-8.5] mL/kg, p < 0.05). ROTEM®
clotting times were shorter (45 [41-48] vs. 49 [45-53]sec, p < 0.05), while maximum clot firmness was slightly lower (68 [67-68] vs. 69 [69-71]mm, p < 0.01).
Organ failure was similar in both groups.
Conclusions: Use of cryopreserved platelets required less transfusion volume
to reach a targeted MAP compared to liquid stored platelets, while organ injury
was similar. These results provide a rationale for clinical trials with
cryopreserved platelets in (traumatic) bleeding